EvokAI Creative Labs Announces Share Consolidation

EvokAI Creative Labs Inc., a MedTech company leveraging AI for healthcare innovations, will proceed with a 10:1 consolidation of its common shares. This will be effective at market opening on February 5, 2025. Post-consolidation, the company will have 7,605,493 common shares outstanding. New CUSIP and ISIN numbers have been issued.

Uncertificated shareholders will automatically have their shares adjusted by Endeavor Trust Corporation. Those with physical certificates will receive instructions to exchange them. The share consolidation seeks to heighten financial interest, improve trading liquidity, and reduce transaction costs.